Overview
Jennifer L. Cohen, MD is an Associate Professor of Pediatrics in the Division of Medical Genetics. She has secondary appointments in Obstetrics and Gynecology and Molecular Genetics & Microbiology. She attended Yale College and then received her MD from the Icahn School of Medicine at Mount Sinai in NYC. She completed a combined residency program at the Children’s Hospital of Philadelphia in Pediatrics and Medical Genetics, before joining the faculty at Duke in 2019. Her research interests and expertise are in perinatal genetic medicine with a current focus on earlier diagnosis and management of rare genetic diseases. She is the physician lead for Pompe disease newborn screening in North Carolina and is actively involved in gene therapy clinical trials for lysosomal storage diseases. Dr. Cohen leads the Duke site for a clinical trial of prenatal enzyme replacement therapy for lysosomal storage diseases. Her long-time research interests and training have led her to pursue the study of in utero treatment for genetic diseases and to advance implementation of more rapid and comprehensive diagnostic testing in fetuses and critically ill infants.
Current Duke Appointments & Affiliations
Recent Scholarly Works
The Expanding Role of Gene Sequencing in Shaping Fetal Therapies: Clinical and Ethical Considerations.
Journal article Prenat Diagn · May 2026 In utero interventions are transformative in addressing genetic and anatomic conditions during fetal development. Next generation sequencing enables early genetic testing, playing a pivotal role in prenatal decision-making by supporting risk stratification ... Full text Link to item CiteEarly Initiation of Enzyme Replacement Therapy in Infantile Onset Pompe Disease Improves Cardiac Outcomes: A Longitudinal Analysis.
Journal article JIMD Rep · January 2026 The objective of this study is to evaluate whether early enzyme replacement therapy (ERT) initiation is associated with a lower incidence of echocardiogram abnormalities and cardiac conduction abnormalities compared to later ERT initiation. We identified a ... Full text Link to item CiteCorrection: Cell-specific expression biases in human cortex of genes associated with neurodevelopmental disorders.
Journal article Sci Rep · September 9, 2025 Full text Link to item CiteRecent Grants
Developing strategies to identify candidate individuals for early genetic therapies
ResearchPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2024 - 2029An Open-label, Dose-Finding, Phase 1/2 Study to Evaluate the Safety and Tolerability of a Single Intravenous Dose of LY3884961 in Patients with Peripheral Manifestations of Gaucher Disease
Clinical TrialPrincipal Investigator · Awarded by Lilly USA, LLC · 2023 - 2027Phase 1 Study of In Utero Enzyme Replacement Therapy for the Treatment of Lysosomal Storage Diseases
ResearchPrincipal Investigator · Awarded by University of California - San Francisco · 2022 - 2027View All Grants